Tin tức & Cập nhật

Gestational diabetes bears increased hazard of microalbuminuria in third trimester
Gestational diabetes bears increased hazard of microalbuminuria in third trimester
04 Oct 2021

Among women with gestational diabetes mellitus, microalbuminuria may occur in the third trimester despite exposure to only a brief period of overt hyperglycaemia, a study has found.

Gestational diabetes bears increased hazard of microalbuminuria in third trimester
04 Oct 2021
Black rice extract helps shed pounds in postmenopausal women
Black rice extract helps shed pounds in postmenopausal women
01 Oct 2021

For postmenopausal women with obesity, 12 weeks of supplementation with black rice extract works to reduce fat accumulation, a recent study has found.

Black rice extract helps shed pounds in postmenopausal women
01 Oct 2021
Severe hypoglycaemia ups risk of adverse outcomes in older patients
Severe hypoglycaemia ups risk of adverse outcomes in older patients
01 Oct 2021

Severe hypoglycaemia is a risk factor for hospitalization and mortality among older patients with diabetes, a study reports. The event may also serve as a marker of future cardiovascular events among those with pre-existing heart disease and obesity.

Severe hypoglycaemia ups risk of adverse outcomes in older patients
01 Oct 2021
Low-carb diets may improve renal, CV risk factors in T2D patients
Low-carb diets may improve renal, CV risk factors in T2D patients
29 Sep 2021 bởiAudrey Abella

In individuals with type 2 diabetes (T2D), low-carbohydrate diets (LCDs) may improve renal and cardiovascular (CV) risk factors, suggests a review from the UK.

Low-carb diets may improve renal, CV risk factors in T2D patients
29 Sep 2021
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021 bởiJairia Dela Cruz

In the treatment of patients with type 2 diabetes mellitus and hypertension, switching from a dipeptidyl peptidase-4 (DPP-4) inhibitor to the sodium-glucose cotransporter-2 (SGLT2) inhibitor luseogliflozin appears to have favourable effects on blood pressure (BP), circadian rhythm, and night-time systolic BP (SBP) and pulse rate (PR), according to data from the open-label LUNA trial.

DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021